As­traZeneca wins fed­er­al class-ac­tion suit, judge dis­miss­es share­hold­er­s' mis­lead­ing claims

As­traZeneca nev­er got its Covid-19 vac­cine au­tho­rized in the US, and while share­hold­ers have tried tak­ing the UK phar­ma to court, a judge has now squashed that ef­fort.

Fed­er­al Judge Paul Oetken of the US South­ern Dis­trict of New York ap­proved the phar­ma com­pa­ny’s mo­tion Mon­day to dis­miss a class ac­tion suit. The law­suit al­leged the com­pa­ny made mis­lead­ing state­ments about the clin­i­cal test­ing of its Covid-19 vac­cine can­di­date AZD1222.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER